Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could two doses of a common drug cut transfusions in hip fracture surgery?

NCT ID NCT07432737

Recruiting now Disease control Sponsor: University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving two doses of tranexamic acid (a drug that helps blood clot) is better than one dose at reducing blood loss and the need for blood transfusions in older adults having hip fracture surgery. The trial includes 120 people aged 65 and older. Participants will receive either one dose before surgery or two doses (one before and one after). Researchers will track blood loss, transfusions, and safety for up to 90 days after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP FRACTURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhage hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP FRACTURES

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Clinic PHI University Clinic for Surgical Diseases, St. Naum Ohridski

    RECRUITING

    Skopje, 1000, North Macedonia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••